Postoperative Adjuvant Chemotherapy for Thymic Cancer (FUSCC-Thymic 3)

Clinical trial NCT06402708 · RECRUITING

Trial details

NCT number: NCT06402708
Sponsor: Fudan University
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Thymic Carcinoma

Start date: 2024-04-09
Primary completion: 2027-05-01
Enrollment: 172

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.